In the striatum, NF-κB binding activity decreased at 3, 6, and 16 h after stroke compared with the control group (Fig. 5B and D) and accounted for 17 ± 9%, 3 ± 3%, and 14 ± 6% of the control group, respectively (p < 0.0001 for each comparison). The gene discussed is NFKB1; the disease is Stroke.